Long-term outcomes of ocular adnexal lymphomas: case series from two lymphoma centers in Brazil
- 18 January 2021
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 62 (4), 1-5
- https://doi.org/10.1080/10428194.2020.1855348
Abstract
Ocular adnexal lymphoma (OAL) refers to extremely rare, heterogeneous, malignant lymphoproliferative disorder that accounts for 55% of all orbital tumors and 5% of extranodal lymphomas. OAL can com...This publication has 10 references indexed in Scilit:
- Clinical features and treatment outcomes of primary ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center retrospective analysis of 64 patients in ChinaInternational Journal of Ophthalmology, 2019
- Orbital Lymphoma—An International Multicenter Retrospective StudyAmerican Journal of Ophthalmology, 2018
- Orbital lymphomaSurvey of Ophthalmology, 2018
- Treatments for Ocular Adnexal LymphomaOphthalmology, 2018
- Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT HistologiesClinical Lymphoma Myeloma and Leukemia, 2017
- Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort studyBlood, 2017
- CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPJournal of Clinical Oncology, 2016
- Primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patientsBritish Journal of Haematology, 2010
- Extranodal marginal zone lymphoma of the ocular adnexaBlood, 2009
- The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphomaAnnals of Oncology, 2006